Search Results - "Ulman, Katherine"
-
1
Elemental Impurities in Pharmaceutical Excipients
Published in Journal of pharmaceutical sciences (01-12-2015)“…Control of elemental impurities in pharmaceutical materials is currently undergoing a transition from control based on concentrations in components of drug…”
Get more information
Journal Article -
2
Passive Transdermal Systems Whitepaper Incorporating Current Chemistry, Manufacturing and Controls (CMC) Development Principles
Published in AAPS PharmSciTech (01-03-2012)“…In this whitepaper, the Manufacturing Technical Committee (MTC) of the Product Quality Research Institute has updated the 1997 Transdermal Drug Delivery…”
Get full text
Journal Article -
3
Mitigating the Risk from Excipient Variability
Published in Pharmaceutical Technology (01-08-2022)“…Particle size is usually controlled as an average or distribution, and dilute solution viscosities are often used for routine analysis to monitor…”
Get full text
Trade Publication Article -
4
Comparison of Pharmaceutical Excipients and Food Ingredient Requirements
Published in Pharmaceutical Technology (01-04-2020)“…[...]it is also incorrect to assume that product approved for use as a pharmaceutical excipient will automatically comply with food or dietary supplement…”
Get full text
Trade Publication Article -
5
Third-Party Audits: Ensuring That Excipients Meet cGMP Requirements
Published in Pharmaceutical Technology (01-09-2018)“…[...]party audits offer a way to reduce the cost of audits, both for the pharmaceutical manufacturer and the excipient supplier. Followup communications…”
Get full text
Trade Publication Article -
6
Establishing limits for dermal absorption of elemental impurities
Published in Pharmaceutical Technology (01-09-2015)“…The International Conference on Harmonization's (ICH's) Q3D Guideline For Elemental Impurities establishes acceptable exposure limits and defines these limits…”
Get full text
Magazine Article Trade Publication Article -
7
Mitigating the Risk from Excipient Variability: This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer
Published in Pharmaceutical technology (2003) (01-08-2022)Get full text
Magazine Article -
8
Elemental impurities: an industry perspective on harmonization and implementation of ICH and USP requirements
Published in Pharmaceutical Technology (01-11-2012)“…The US Pharmacopeia's revised General Chapters on elemental impurity limits and testing procedures are set to take effect in December 2012, and are to be…”
Get full text
Magazine Article Trade Publication Article -
9
-
10
Additives and Processing Aids in Pharmaceutical Excipients
Published in Pharmaceutical Technology (01-10-2019)“…[...]there are a large number of excipients in approved medicines that contain undeclared additives, processing aids, and/or concomitant components…”
Get full text
Trade Publication Article -
11
Third-Party Audits: Ensuring That Excipients Meet cGMP Requirements: Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials
Published in Pharmaceutical technology (2003) (01-09-2018)Get full text
Magazine Article -
12
Implementation of ICH Q3D Elemental Impurities Guideline: Challenges and Opportunities
Published in Pharmaceutical Technology (01-03-2015)“…New guidelines relating to elemental impurities from the International Conference on Harmonization (ICH), Q3D Guideline for Elemental Impurities have presented…”
Get full text
Trade Publication Article -
13